FDA Adverse Event Injury Summary report: N

SOCLEAN II

MDR report key: 11825009 · Received May 13, 2021

Report

Report Number
MW5101354
Event Type
Injury
Date Received
May 13, 2021
Date of Event
May 4, 2021
Report Date
May 11, 2021
Manufacturer
SOCLEAN, INC.
Product Code
LRJ
Adverse Event
Yes
Product Problem
Yes
Report Source
Voluntary report
Reporter Location
NY, US
Reporter Occupation
PATIENT FAMILY MEMBER OR FRIEND

Narratives

Description of Event or Problem · 1

BLOOD PRESSURE SOARED; WE PURCHASED A SOCLEAN II TO CLEAN HUSBAND'S CPAP MACHINE. AFTER USING ONLY ONCE, PLUS A TEST RUN, HE SUFFERED TOXIC OZONE EXPOSURE. HE FELT WOOZY; HE IS A HEART PATIENT ALSO ON BLOOD PRESSURE MEDICATION. I TOOK HIS BLOOD PRESSURE. IT WAS 188/118! WE TOOK HIS BLOOD PRESSURE EVERY 5 MINUTES FOR 45 MINUTES. IT WENT DOWN A LITTLE BUT WAS STILL IN THE 170S/100-110S. WE CALLED HIS PRIMARY PHYSICIAN WHO SAW HIM IMMEDIATELY. HE LISTENED TO THE HEART, DID AN EKG, TOOK BLOOD PRESSURE. HE TOLD US THAT OZONE CAN DEFINITELY RAISE BLOOD PRESSURE. THE ONLY CONTRAINDICATIONS LIST FOR THIS PRODUCT IS IN THE MANUAL INSIDE THE BOX WHICH YOU ONLY SEE AFTER PURCHASE. THE DOCTOR TOLD US TO STOP USING AND IMMEDIATELY RETURN IT, WHICH WE DID. NOW I READ ON THE FDA WEBSITE THAT THIS MACHINE IS NOT APPROVED FOR USE IN THE US. ALSO, CONTINUED USE OF BOTH THE OZONE CLEANERS AND EVEN THE ULTRAVIOLET CLEANERS CAN DAMAGE THE MACHINE, TO SAY NOTHING OF THE DAMAGE TO THE PATIENT'S HEALTH. AFTER WE RETURNED FROM THE DOCTOR, EVEN AFTER OPENING WINDOWS AND RUNNING FANS, I COULDN'T BELIEVE HOW SATURATED THE AIR WAS IN THE BEDROOM WHERE BOTH THE CPAP AND SOCLEAN II WERE LOCATED. THERE SHOULD BE SOME SORT OF BLACK BOX WARNING OR, BETTER YET, A VERY PUBLIC WARNING AS TO JUST HOW DANGEROUS THIS PRODUCT IS. A PERSON WITH A DIMINISHED SENSE OF SMELL COULD EVEN SUCCUMB TO THE OZONE WITH CONTINUED USE. FDA SAFETY REPORT ID# (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
717418 SOCLEAN II DISINFECTANT, MEDICAL DEVICES LRJ SOCLEAN, INC.

Patients

Seq Age Sex Outcome Treatment
1 76 YR Other